What is the median sales figure for the Bottom 25% of Learningrx centers?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
| Sample: | Top 25% | Mid-Top | Mid-Lower | Bottom | |
|---|---|---|---|---|---|
| 25% | 25% | 25% | |||
| # of Centers: | 11 | 10 | 10 | 10 | 4 |
| Top Sales | $893,375 | $486,808 | $287,188 | $167,835 | $376,730 |
| Low Sales | $507,737 | $300,712 | $172,105 | $35,673 | $133,094 |
| Median Sales | $601,971 | $391,046 | $229,711 | $75,215 | $195,526 |
| Average Sales | $631,577 | $402,343 | $229,935 | $85,218 | $225,219 |
| Centers meeting or | 2 / 18% | 5 / 50% | 5 / 50% | 3 / 30% | 1 / 25% |
| exceeding average: |
Source: Item 19 — FINANCIAL PERFORMANCE REPRESENTATIONS (FDD pages 46–48)
What This Means (2025 FDD)
According to Learningrx's 2025 Franchise Disclosure Document, the median sales for the bottom 25% of centers was $75,215. This data is based on the financial performance of 45 Learningrx franchised centers that had complete data and were open for the full 12 months during the fiscal year ending September 30, 2024.
For a prospective franchisee, this figure represents the midpoint of sales performance for the lowest-performing group of centers. It suggests that half of the centers in the bottom 25% achieved sales below $75,215, while the other half exceeded it. Understanding this number is crucial for setting realistic expectations about potential revenue during the initial years of operation.
It is important to note that Learningrx emphasizes that individual results may vary, and there is no assurance that a new franchisee will achieve similar or better sales figures. The FDD also states that written substantiation for the financial performance representation will be made available to the prospective franchisee upon reasonable request. Prospective franchisees should carefully review this substantiation and consider factors such as location, market conditions, and their own management capabilities when evaluating the potential financial performance of a Learningrx franchise.